Page 64 - AN-1-3

Advanced Neurology Targets and medications for AVM of CNS

48. Meng J, Okeda R, 2001, Histopathological structure of the KRAS/BRAF somatic mutations in brain and spinal cord
pial arteriovenous malformation in adults: Observation by arteriovenous malformations. Brain, 142(1): 23-34.
reconstruction of serial sections of four surgical specimens. https://doi.org/10.1093/brain/awy307
Acta Neuropathol, 102(1):63-68.
59. Fish JE, Suarez CP, Boudreau E, et al., 2020, Somatic gain
https://doi.org/10.1007/s004010000351
of kras function in the endothelium is sufficient to cause
49. Chen W, Guo Y, Walker EJ, et al., 2013, Reduced mural vascular malformations that require MEK but not PI3K
cell coverage and impaired vessel integrity after angiogenic signaling. Circ Res, 127(6): 727-743.
stimulation in the Alk1-deficient brain. Arterioscler Thromb https://doi.org/10.1161/CIRCRESAHA.119.316500
Vasc Biol, 33(2): 305-310.
60. Park ES, Kim S, Huang S, et al., 2021, Selective endothelial
https://doi.org/10.1161/ATVBAHA.112.300485
hyperactivation of oncogenic KRAS induces brain
50. Baeyens N, Larrivée B, Ola R, et al., 2016, Defective fluid arteriovenous malformations in mice. Ann Neurol, 89(5):
shear stress mechanotransduction mediates hereditary 926-941.
hemorrhagic telangiectasia. J Cell Biol, 214(7): 807-816.
https://doi.org/10.1002/ana.26059
https://doi.org/10.1083/jcb.201603106
61. Edwards EA, Phelps AS, Cooke D, et al., 2020, Monitoring
51. Winkler EA, Birk H, Burkhardt JK, et al., 2018, Reductions arteriovenous malformation response to genotype-targeted
in brain pericytes are associated with arteriovenous therapy. Pediatrics, 146(3):e20193206.
malformation vascular instability. J Neurosurg, https://doi.org/10.1542/peds.2019-3206
129(6): 1464-1474.
62. Nicholson CL, Flanagan S, Murati M, et al., 2022, Successful
https://doi.org/10.3171/2017.6.JNS17860
management of an arteriovenous malformation with
52. Lebrin F, Srun S, Raymond K, et al., 2010, Thalidomide trametinib in a patient with capillary-malformation
stimulates vessel maturation and reduces epistaxis in arteriovenous malformation syndrome and cardiac
individuals with hereditary hemorrhagic telangiectasia. Nat compromise. Pediatr Dermatol, 39(2): 316-319.
Med, 16(4): 420-428.
https://doi.org/10.1111/pde.14912
https://doi.org/10.1038/nm.2131
63. Lekwuttikarn R, Lim YH, Admani S, et al., 2019, Genotype-
53. Invernizzi R, Quaglia F, Klersy C, et al., 2015, Efficacy and guided medical treatment of an arteriovenous malformation
safety of thalidomide for the treatment of severe recurrent in a child. JAMA Dermatol, 155(2): 256-257.
epistaxis in hereditary haemorrhagic telangiectasia: Results https://doi.org/10.1001/jamadermatol.2018.4653
of a non-randomised, single-centre, phase 2 study. Lancet
Haematol, 2(11):e465-e473. 64. Al‐Samkari H, Eng W, 2022, A precision medicine approach
to hereditary hemorrhagic telangiectasia and complex
https://doi.org/10.1016/S2352-3026(15)00195-7
vascular anomalies. J Thromb Haemost, 20(5): 1077-1088.
54. Ge Z, Chen H, Gao Y, et al., 2011, Efficacy of thalidomide https://doi.org/10.1111/jth.15715
for refractory gastrointestinal bleeding from vascular
malformation. Gastroenterology, 141(5): 1629-1637.e1-4. 65. Winkler E, Wu D, Gil E, et al., 2022, Endoluminal biopsy for
molecular profiling of human brain vascular malformations.
https://doi.org/10.1053/j.gastro.2011.07.018
Neurology, 98(16):e1637-e1647.
55. Tseng S, Pak G, Washenik K, et al., 1996, Rediscovering https://doi.org/10.1212/WNL.0000000000200109
thalidomide: A review of its mechanism of action, side effects,
and potential uses. J Am Acad Dermatol, 35(6):969-979. 66. Nguyen HL, Boon LM, Vikkula M, 2022, Trametinib as a
promising therapeutic option in alleviating vascular defects
https://doi.org/10.1016/S0190-9622(96)90122-X
in an endothelial KRAS-induced mouse model. Hum Mol
56. Couto JA, Huang AY, Konczyk DJ, et al., 2017, Somatic Genet, ddac169.
MAP2K1 mutations are associated with extracranial https://doi.org/10.1093/hmg/ddac169
arteriovenous malformation. Am J Hum Genet,
100(3):546-554. 67. Liu AS, Mulliken JB, Zurakowski D, et al., 2010, Extracranial
arteriovenous malformations: Natural progression
https://doi.org/10.1016/j.ajhg.2017.01.018
and recurrence after treatment. Plast Reconstr Surg,
57. Morita H, Komuro I, 2018, Somatic activating KRAS 125(4): 1185-1194.
mutations in arteriovenous malformations of the brain. https://doi.org/10.1097/PRS.0b013e3181d18070
N Engl J Med, 378(16): 1561-1562.
68. Murphy PA, Kim TN, Lu G, et al., 2012, Notch4
https://doi.org/10.1056/NEJMc1802190
normalization reduces blood vessel size in arteriovenous
58. Hong T, Yan Y, Li J, et al., 2019, High prevalence of malformations. Sci Transl Med, 4(117): 117ra8.

Volume 1 Issue 3 (2022) 10 https://doi.org/10.36922/an.v1i3.211